U S Physical Therapy (USPH) FY2015 results: revenue $331 million, up 8.6% on the year
U S Physical Therapy Inc. (USPH) reported revenue of $331 million for fiscal 2015, the year ended 31 December 2015, up 8.6% on the year before. Net income was $21 million, up 7.8%, and diluted earnings per share $1.77. The figures are the company's own, from the 10-K it filed with the SEC on 4 March 2016.
Revenue
$331 million
+8.6% on the year
FY2009FY2015
Operating margin
14.3%
15.0% a year earlier
FY2009FY2015
Net income
$21 million
+7.8% on the year
FY2009FY2015
Diluted EPS
$1.77
+12.7% on the year
FY2009FY2015
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Revenue
331
305
264
+8.6%
Gross profit
78.4
76.2
64.7
+2.9%
Gross margin
23.7%
25.0%
24.5%
Selling, general and administrative
31.1
30.4
25.9
+2.2%
Operating income
47.3
45.8
38.8
+3.3%
Operating margin
14.3%
15.0%
14.7%
Interest expense
7.2
7.5
0.5
-2.9%
Pre-tax income
40.1
38.3
38.2
+4.7%
Income tax
13.6
13.0
12.2
+4.8%
Effective tax rate
34.0%
34.0%
32.0%
Net income
20.6
19.1
12.7
+7.8%
Net margin
6.2%
6.3%
4.8%
Diluted EPS
$1.77
$1.57
$1.05
+12.7%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Operating cash flow
37.5
45.2
44.8
-17.0%
Capital expenditure
6.3
5.2
4.6
+21.2%
Free cash flow
31.3
40.0
40.2
-21.9%
Free cash flow margin
9.4%
13.1%
15.2%
Cash from investing
-26.1
-22.9
-52.4
Cash from financing
-9.9
-20.9
8.9
Depreciation and amortisation
8.0
6.7
5.6
+18.0%
Share-based compensation
4.5
3.4
2.7
+33.5%
Dividends paid
7.4
5.9
4.8
+26.8%
Dividend per share
$0.60
$0.48
$0.40
+25.0%
Diluted shares, weighted
12m
12m
12m
+1.4%
Balance sheet
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Shareholders' equity
171
146
128
+16.9%
Non-controlling interest
1.3
20.9
22.7
-94.0%
Redeemable equity
0.0
7.4
4.1
Debt
49.1
35.6
41.5
+37.9%
Other liabilities
82.3
34.3
27.5
+139.7%
Total liabilities and equity
304
245
224
+24.2%
Fixed assets
16.7
15.8
15.0
+5.6%
Goodwill
195
172
144
+13.8%
Intangible assets
30.3
24.9
14.5
+21.6%
Cash and equivalents
15.8
14.3
12.9
+10.6%
Receivables
36.2
32.9
n/a
+10.2%
Other assets
9.4
n/a
37.8
Total assets
304
245
224
+24.2%
10-K for the year ended 31 December 2015, filed 4 March 2016: the filing.